Literature DB >> 1986683

Serum and lavage lactate dehydrogenase isoenzymes in pulmonary alveolar proteinosis.

R M Hoffman1, R M Rogers.   

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the accumulation of lipoproteinaceous material in the alveolar space. Serum lactate dehydrogenase (LDH) has been noted to be elevated in patients with PAP in previous studies. We sought to extend this observation in a series of patients with PAP by looking at total serum LDH concentrations and LDH isoenzyme fractions measured before and after whole lung lavage. Total LDH and LDH isoenzymes were also determined in the lavage effluent. Total serum LDH was elevated before lavage in 10 of 16 patients. Prelavage serum LDH and prelavage alveolar-arterial O2 gradient showed a significant correlation (r = 0.62, p less than 0.05). A decrease in serum LDH was found after lavage in all patients in whom postlavage data was available (paired t test, p less than 0.01, n = 11), although the magnitude of this decrease varied considerably. The isoenzyme pattern before lavage was isomorphic, and this pattern was unchanged after whole lung lavage. This was in marked contrast to the LDH isoenzyme pattern observed in the lavage effluent, which showed a lower percent LDH1 and LDH2 and a higher percent LDH3, LDH4, and LDH5 when compared with the corresponding prelavage isoenzyme percentages for serum (unpaired t test, p less than 0.001). There was no correlation between the total serum LDH concentration and the total lavage LDH concentration. These data confirm that elevated serum LDH is a common finding in PAP. Furthermore, the LDH elevation found consistently in the alveolar fluid points to this as the source of the serum LDH.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986683     DOI: 10.1164/ajrccm/143.1.42

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  The value of BAL fluid LDH level in differentiating benign from malignant solitary pulmonary nodules.

Authors:  Ali Emad; Vahid Emad
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-20       Impact factor: 4.553

Review 3.  Secondary alveolar proteinosis in cancer patients.

Authors:  S Ladeb; J Fleury-Feith; E Escudier; J Tran Van Nhieu; J F Bernaudin; C Cordonnier
Journal:  Support Care Cancer       Date:  1996-11       Impact factor: 3.603

Review 4.  Rare lung disease II: pulmonary alveolar proteinosis.

Authors:  Stephen C Juvet; David Hwang; Thomas K Waddell; Gregory P Downey
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

5.  LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity.

Authors:  Federico R Laham; Amanda A Trott; Berkeley L Bennett; Claudia A Kozinetz; Alan M Jewell; Roberto P Garofalo; Pedro A Piedra
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

6.  Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency.

Authors:  Jin-liang Liu; Feng Xu; Hui Zhou; Xue-jie Wu; Ling-xian Shi; Rui-qing Lu; Alessio Farcomeni; Mario Venditti; Ying-li Zhao; Shu-ya Luo; Xiao-jun Dong; Marco Falcone
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

7.  Clinical significance of cigarette smoking and dust exposure in pulmonary alveolar proteinosis: a Korean national survey.

Authors:  Ji An Hwang; Joo Han Song; Jung Hoon Kim; Man Pyo Chung; Dong Soon Kim; Jin Woo Song; Young Whan Kim; Sun Mi Choi; Seung Ick Cha; Soo Taek Uh; Choon-Sik Park; Sung Hwan Jeong; Yong Bum Park; Hong Lyeol Lee; Jong Wook Shin; Eun Joo Lee; Yangjin Jegal; Hyun Kyung Lee; Jong Sun Park; Moo Suk Park
Journal:  BMC Pulm Med       Date:  2017-11-21       Impact factor: 3.317

8.  BN 52021 (a platelet activating factor-receptor antagonist) decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis.

Authors:  J L Pérez-Arellano; T Martín; J M López-Novoa; M L Sánchez; A Montero; A Jiménez
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

9.  Role of lysosomal enzymes released by alveolar macrophages in the pathogenesis of the acute phase of hypersensitivity pneumonitis.

Authors:  J L Pérez-Arellano; M N Barrios; T Martín; M L Sánchez; J M Buitrago; A Jiménez
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

Review 10.  The Clinical Clues of Pulmonary Alveolar Proteinosis: A Report of 11 Cases and Literature Review.

Authors:  Qiongya Mo; Bingbin Wang; Nian Dong; Lianmin Bao; Xiaoqiong Su; Yuping Li; Chengshui Chen
Journal:  Can Respir J       Date:  2016-04-26       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.